NCT00174512已完成1 期
A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 36
- 试验地点
- 6
- 主要终点
- QT and QTc changes at two different pacing rates in atrially paced patients
研究概览
简要总结
To assess the effects of GTN on QT and QTc in subjects with And without atrial pacing. This will be done with and without autonomic blockade at two different pacing rates. Moxifloxacin effect on QT and QTc will also be assessed in atrially paced patients at two different pacing rates with and without autonomic blockade
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Ect
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with pace-makers but otherwise normal ventricular function
排除标准
- •Nitrates, beta blockers
结局指标
主要结局
QT and QTc changes at two different pacing rates in atrially paced patients
次要结局
- Change in QT and QTcF before and after Moxifloxacin with and without autonomic blockade at each pacing rate Change in QT and QTcF before and after autonomic blockade at each pacing rate
研究者
研究点 (6)
Loading locations...
相似试验
已完成
1 期
A QT/QTc Evaluation Study of TS-142 in Healthy Adult SubjectsInsomniaJPRN-jRCT2071210018Mita Seiji48
已完成
1 期
A QT/QTc Evaluation Study of TS-142 in Healthy Adult SubjectsHealthy SubjectsNCT04873323Taisho Pharmaceutical Co., Ltd.59
已完成
1 期
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained PatientsOpioid DependenceMethadone Withdrawal SyndromeNCT01650649USWM, LLC (dba US WorldMeds)27
已完成
1 期
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineSchizophreniaSchizoaffective DisorderNCT00791622Johnson & Johnson Pharmaceutical Research & Development, L.L.C.110
已完成
1 期
A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult ParticipantsHealthyNCT05387759Janssen Research & Development, LLC60
